DK158743C - Fremgangsmaade til fremstilling af et levende, svaekket hepatitis a virus og diagnostisk praeparat opnaaet ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af et levende, svaekket hepatitis a virus og diagnostisk praeparat opnaaet ved fremgangsmaaden

Info

Publication number
DK158743C
DK158743C DK343179A DK343179A DK158743C DK 158743 C DK158743 C DK 158743C DK 343179 A DK343179 A DK 343179A DK 343179 A DK343179 A DK 343179A DK 158743 C DK158743 C DK 158743C
Authority
DK
Denmark
Prior art keywords
hepatitis
procedure
virus
weaked
living
Prior art date
Application number
DK343179A
Other languages
Danish (da)
English (en)
Other versions
DK343179A (da
DK158743B (da
Inventor
Philip J Provost
Maurice R Hilleman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK343179A publication Critical patent/DK343179A/da
Publication of DK158743B publication Critical patent/DK158743B/da
Application granted granted Critical
Publication of DK158743C publication Critical patent/DK158743C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK343179A 1978-08-17 1979-08-16 Fremgangsmaade til fremstilling af et levende, svaekket hepatitis a virus og diagnostisk praeparat opnaaet ved fremgangsmaaden DK158743C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/934,293 US4164566A (en) 1978-08-17 1978-08-17 Hepatitis a virus cell culture in vitro
US93429378 1978-08-17

Publications (3)

Publication Number Publication Date
DK343179A DK343179A (da) 1980-02-18
DK158743B DK158743B (da) 1990-07-09
DK158743C true DK158743C (da) 1990-12-10

Family

ID=25465313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK343179A DK158743C (da) 1978-08-17 1979-08-16 Fremgangsmaade til fremstilling af et levende, svaekket hepatitis a virus og diagnostisk praeparat opnaaet ved fremgangsmaaden

Country Status (8)

Country Link
US (1) US4164566A (de)
EP (1) EP0008559B1 (de)
JP (1) JPS5548389A (de)
AT (1) ATE2014T1 (de)
CA (1) CA1135621A (de)
DE (1) DE2964276D1 (de)
DK (1) DK158743C (de)
IE (1) IE48399B1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268122B1 (en) 1978-12-22 2001-07-31 Biogen, Inc. Recombinant DNA molecules and their method of production
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
PT71739B (en) 1979-09-04 1982-01-26 Merck & Co Inc Process for preparing a cell culture of hepatitis a virus
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
PT72015B (en) * 1979-11-13 1982-06-20 Merck & Co Inc Process for preparing "invitro" cultures of hepatitis b virus
US4382076A (en) * 1979-11-26 1983-05-03 Merck & Co., Inc. Hepatitis A antibody assay
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US4301249A (en) * 1980-07-23 1981-11-17 Merck & Co., Inc. High titer production of hepatitis A virus
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
DE3135599A1 (de) * 1981-09-09 1983-08-25 Flehmig Bertram An menschliche fibroblastenzellen adaptierte hepatitis-a-viren
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4412002A (en) * 1982-02-26 1983-10-25 Merck & Co., Inc. Process for preparing hepatitis A virus
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175
US4894228A (en) * 1982-04-07 1990-01-16 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus
US4636469A (en) * 1982-04-07 1987-01-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Isolation of hepatitis A virus strain HM-175
US5478746A (en) * 1982-04-07 1995-12-26 The United States Of America As Represented By The Department Of Health And Human Services cDNA encoding attenuated cell culture adapted hepatitis A virus genome
US4620978A (en) * 1982-04-07 1986-11-04 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis A virus purified and triply cloned
USRE37381E1 (en) * 1982-04-07 2001-09-18 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus
CA1324094C (en) * 1985-04-03 1993-11-09 Dino Dina Hepatitis a virus vaccines
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
JPS63502962A (ja) * 1986-04-01 1988-11-02 ジーンラブズ　インコーポレイテッド ウイルス特異的な永久増殖性組織細胞
DE3633550A1 (de) * 1986-10-02 1988-04-14 Behringwerke Ag Vaccine gegen hepatitis a
NZ225583A (en) * 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)
JPH0751513B2 (ja) * 1988-04-28 1995-06-05 国立予防衛生研究所長 Ａ型肝炎ワクチン
JPH085804B2 (ja) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 Ａ型及びｂ型肝炎混合アジュバントワクチン
JPH0761955B2 (ja) * 1988-04-28 1995-07-05 国立予防衛生研究所長 凍結乾燥ａ型肝炎ワクチン
US6117674A (en) * 1988-06-30 2000-09-12 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Pathogen propagation in cultured three-dimensional tissue mass
WO1992019268A1 (en) * 1991-05-08 1992-11-12 Schweiz. Serum- & Impfinstitut Bern New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
US5549896A (en) * 1991-05-08 1996-08-27 Schweiz. Serum- & Impfinstitut Bern Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
DZ1706A1 (fr) 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US6190859B1 (en) 1995-04-17 2001-02-20 The United States Of America As Represented By The Secretary Of The Army Method and kit for detection of dengue virus
US6562562B2 (en) * 2000-03-10 2003-05-13 Pharmacia & Upjohn S.P.A. Procedure for partial liver resection in nonhuman primates
CA2829774C (en) 2011-03-14 2019-09-24 National Research Council Of Canada Method of viral production in cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105011A (en) * 1961-06-19 1963-09-24 Parke Davis & Co Antigens and process of producing same
US3935066A (en) * 1969-07-03 1976-01-27 Burroughs Wellcome Co. Cell lines
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen
US4031203A (en) * 1974-12-09 1977-06-21 Merck & Co., Inc. Hepatitis A antigen
FR2398504A1 (fr) * 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a

Also Published As

Publication number Publication date
DK343179A (da) 1980-02-18
EP0008559A1 (de) 1980-03-05
JPH0157954B2 (de) 1989-12-08
US4164566A (en) 1979-08-14
EP0008559B1 (de) 1982-12-15
IE48399B1 (en) 1985-01-09
DE2964276D1 (en) 1983-01-20
DK158743B (da) 1990-07-09
ATE2014T1 (de) 1982-12-15
JPS5548389A (en) 1980-04-07
CA1135621A (en) 1982-11-16
IE791575L (en) 1980-02-17

Similar Documents

Publication Publication Date Title
DK158743C (da) Fremgangsmaade til fremstilling af et levende, svaekket hepatitis a virus og diagnostisk praeparat opnaaet ved fremgangsmaaden
DK2251419T3 (da) Porcint reproduktions- og respirations-syndrom-vaccine baseret på isolat JA-142
DE69206631D1 (de) Impfstoff gegen das Fortpflanzungs- und Atmungssyndrom bei Schweinen (PRRS) und Diagnose.
ATE7855T1 (de) Herstellung von virusantigenen.
ES2038689T3 (es) Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
ES466359A1 (es) Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia.
GB1049386A (en) Improvements in or relating to stabilized virus antigens
DK481480A (da) Fremgangsmaade til dyrining af hepatitis b virus
ES8107024A1 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
DE68927380D1 (de) Impfstoff
Tobin The production of antibodies in cotton rats by living and killed poliomyelitis viruses
ZA924654B (en) Attenuated revertant serotype 1 marek's disease vaccine
Husson-van Vliet Comparison of two cellular supports for control of the temperature marker of attenuated poliovirus strains.
DK90128C (da) Fremgangsmåde til fremstilling af en vandig vævskulturvæske, indeholdende en høj koncentration af levende >>smitsom hepatitis<<-virus.
KR790000405B1 (en) Method of manufacturing influenza vaccines
DK91138C (da) Fremgangsmåde til fremstilling af >>smitsom hepatitis<<-virusvaccine.
JPS56131385A (en) Cultivation of virus of hydrophobia

Legal Events

Date Code Title Description
PUP Patent expired